Viking Global’s $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nordisk.
Viking Global’s $45 million investment in Metsera, a biotech company is caught in a bidding war between Pfizer and Novo Nordisk.